HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Becker, M. A. Articles by Kim, M. Search for Related Content PubMed PubMed Citation Articles by Becker, M. A. Articles by Kim, M. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 262, Issue 30, 14531-14537, 10, 1987

Regulation of purine synthesis de novo in human fibroblasts by purine nucleotides and phosphoribosylpyrophosphate

MA Becker and M Kim
Department of Medicine, University of Chicago Pritzker School of Medicine, Illinois 60637.

Previous studies of purine nucleotide synthesis de novo have suggested that major regulation of the rate of the pathway is affected at either the phosphoribosylpyrophosphate (PP-Rib-P) synthetase reaction or the amidophosphoribosyltransferase (amido PRT) reaction, or both. We studied control of purine synthesis de novo in cultured normal, hypoxanthine-guanine phosphoribosyltransferase (HGPRT)-deficient, and PP-Rib-P synthetase-superactive human fibroblasts by measuring concentrations and rates of synthesis of PP-Rib-P and purine nucleotide end products, proposed effectors of regulation, during inhibition of the pathway. Incubation of cells for 90 min with 0.1 mM azaserine, a glutamine antagonist which specifically blocked the pathway at the level of conversion of formylglycinamide ribotide, resulted in a 5-16% decrease in purine nucleoside triphosphate concentrations but no consistent alteration in generation of PP-Rib-P. During this treatment, however, rates of the early steps of the pathway were increased slightly (9-15%) in normal and HGPRT-deficient strains, more markedly (32-60%) in cells with catalytically superactive PP-Rib-P synthetases, and not at all in fibroblasts with purine nucleotide feedback-resistant PP-Rib-P synthetases. In contrast, glutamine deprivation, which inhibited the pathway at the amido PRT reaction, resulted in time- dependent nucleoside triphosphate pool depletion (26-43% decrease at 24 h) accompanied by increased rates of PP-Rib-P generation and, upon readdition of glutamine, substantial increments in rates of purine synthesis de novo. Enhanced PP-Rib-P generation during glutamine deprivation was greatest in cells with regulatory defects in PP-Rib-P synthetase (2-fold), but purine synthesis in these cells was stimulated only 1.4-fold control rates by glutamine readdition. Stimulation of these processes in normal and HGPRT-deficient cells and in cells with PP-Rib-P synthetase catalytic defects was, respectively: 1.5 and 2.0- fold; 1.5 and 1.7-fold; and 1.6 and 4.1-fold. These studies support the following concepts. 1) Rates of purine synthesis de novo are regulated at both the PP-Rib-P synthetase and amido PRT reactions by end products, with the latter reaction more sensitive to small changes in purine nucleotide inhibitor concentrations. 2) PP-Rib-P exerts its role as a major regulator of purine synthetic rate by virtue of its interaction with nucleotide inhibitors to determine the activity of amido PRT. 3) Activation of amido PRT by PP-Rib-P is nearly maximal at base line in fibroblasts with regulatory defects in PP-Rib-P synthetase.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. An, R. Kumar, E. D. Sheets, and S. J. Benkovic Reversible Compartmentalization of de Novo Purine Biosynthetic Complexes in Living Cells Science, April 4, 2008; 320(5872): 103 - 106. [Abstract] [Full Text] [PDF]

				N. Malmanche and D. V. Clark Drosophila melanogaster Prat, a Purine de Novo Synthesis Gene, Has a Pleiotropic Maternal-Effect Phenotype Genetics, December 1, 2004; 168(4): 2011 - 2023. [Abstract] [Full Text] [PDF]

				D. I. Fisher, S. T. Safrany, P. Strike, A. G. McLennan, and J. L. Cartwright Nudix Hydrolases That Degrade Dinucleoside and Diphosphoinositol Polyphosphates Also Have 5-Phosphoribosyl 1-Pyrophosphate (PRPP) Pyrophosphatase Activity That Generates the Glycolytic Activator Ribose 1,5-Bisphosphate J. Biol. Chem., November 27, 2002; 277(49): 47313 - 47317. [Abstract] [Full Text] [PDF]

				M. Ahmed, W. Taylor, P. R. Smith, and M. A. Becker Accelerated Transcription of PRPS1 in X-linked Overactivity of Normal Human Phosphoribosylpyrophosphate Synthetase J. Biol. Chem., March 12, 1999; 274(11): 7482 - 7488. [Abstract] [Full Text] [PDF]

				T. Yamaoka, M. Kondo, S. Honda, H. Iwahana, M. Moritani, S. Ii, K. Yoshimoto, and M. Itakura Amidophosphoribosyltransferase Limits the Rate of Cell Growth-linked de Novo Purine Biosynthesis in the Presence of Constant Capacity of Salvage Purine Biosynthesis J. Biol. Chem., July 11, 1997; 272(28): 17719 - 17725. [Abstract] [Full Text] [PDF]

				M. A. Becker, W. Taylor, P. R. Smith, and M. Ahmed Overexpression of the Normal Phosphoribosylpyrophosphate Synthetase 1Isoform Underlies Catalytic Superactivity of Human Phosphoribosylpyrophosphate Synthetase J. Biol. Chem., August 16, 1996; 271(33): 19894 - 19899. [Abstract] [Full Text] [PDF]

				T. Yamaoka, M. Yano, M. Kondo, H. Sasaki, S. Hino, R. Katashima, M. Moritani, and M. Itakura Feedback Inhibition of Amidophosphoribosyltransferase Regulates the Rate of Cell Growth via Purine Nucleotide, DNA, and Protein Syntheses J. Biol. Chem., June 8, 2001; 276(24): 21285 - 21291. [Abstract] [Full Text] [PDF]